Drug Maker Hit With Stock Drop Suit Over Fibrotic Disease Treatment Drug

(March 15, 2019, 10:39 AM EDT) -- BOSTON — An investor filed a securities class action lawsuit against a pharmaceutical company and two of its senior officers on March 12, alleging that the defendants misrepresented the clinical trial...
To view the full article, register now.